{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T04:19:16Z","timestamp":1767413956987,"version":"3.48.0"},"reference-count":16,"publisher":"Japan Atherosclerosis Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2026,1,1]]},"DOI":"10.5551\/jat.65360","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T22:07:30Z","timestamp":1755036450000},"page":"109-115","source":"Crossref","is-referenced-by-count":0,"title":["Safe Continuation of Apheresis during Pregnancy using the Double-Filtration Plasmapheresis Thermo Mode in a Pregnant Female with Familial Hypercholesterolemia: A Case Report"],"prefix":"10.5551","volume":"33","author":[{"given":"Yoshimasa","family":"Sakurabu","sequence":"first","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruhito A.","family":"Uchida","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Okuyama","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eriko","family":"Eto","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Okayama University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanako","family":"Takasugi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiko","family":"Asakawa","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuyoshi","family":"Katayama","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shugo","family":"Okamoto","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Onishi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsumi","family":"Matsuoka-Uchiyama","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chihiro","family":"Fujihara","sequence":"additional","affiliation":[{"name":"Department of Clinical Engineering Center, Okayama University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidemi","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoko","family":"Umebayashi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuyuki","family":"Tanabe","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Wada","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Varghese MJ. Familial hypercholesterolemia: A review. Ann Pediatr Cardiol, 2014; 7: 107-117","DOI":"10.4103\/0974-2069.132478"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Amundsen AL, Khoury J, Sandset PM, Seljeflot I, Ose L, Tonstad S, Henriksen T, Retterst\u00f8l K, Iversen PO. Altered hemostatic balance and endothelial activation in pregnant women with familial hypercholesterolemia. Thromb Res, 2007; 120: 21-27","DOI":"10.1016\/j.thromres.2006.07.001"},{"key":"3","unstructured":"3) EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC). Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC). Lancet, 2021; 398: 1713-1725"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Hutter CM, Austin MA, Humphries SE. Familial hypercholesterolemia, peripheral arterial disease, and stroke: a HuGE minireview. Am J Epidemiol, 2004; 160: 430-435","DOI":"10.1093\/aje\/kwh238"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Harada-Shiba M, Sugisawa T, Makino H, Abe M, Tsushima M, Yoshimasa Y, Yamashita T, Miyamoto Y, Yamamoto A, Tomoike H, Yokoyama S. Impact of statin treatment on the clinical fate of heterozygous familial hypercholesterolemia. J Atheroscler Thromb, 2010; 17: 667-674","DOI":"10.5551\/jat.4143"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Raal FJ, Pilcher GJ, Panz VR, van Deventer HE, Brice BC, Blom DJ, Marais AD. Reduction in mortality in subjects with homozygous familial hypercholesterolemia associated with advances in lipid-lowering therapy. Circulation, 2011; 124: 2202-2207","DOI":"10.1161\/CIRCULATIONAHA.111.042523"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Lewek J, Bielecka-D\u0105browa A, Toth PP, Banach M. Dyslipidaemia management in pregnant patients: a 2024 update. Eur Heart J Open, 2024; 4: oeae032","DOI":"10.1093\/ehjopen\/oeae032"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Al-Baldawi Z, Brown L, Ruel I, Baass A, Bergeron J, Cermakova L, Couture P, Gaudet D, Francis GA, Hegele RA, Iatan I, Mancini GBJ, McCrindle BW, Ransom T, Sherman MH, McPherson R, Genest J, Brunham LR. Sex differences in the presentation, treatment and outcomes of patients with homozygous familial hypercholesterolemia. J Clin Lipidol, 2024;18: e189-e196","DOI":"10.1016\/j.jacl.2024.01.003"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Amundsen AL, Khoury J, Iversen PO, Bergei C, Ose L, Tonstad S, Retterst\u00f8l K. Marked changes in plasma lipids and lipoproteins during pregnancy in women with familial hypercholesterolemia. Atherosclerosis, 2006; 189: 451-457","DOI":"10.1016\/j.atherosclerosis.2006.01.002"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Beigel Y, Bar J, Cohen M, Hod M. Pregnancy outcome in familial homozygous hypercholesterolemic females treated with long-term plasma exchange. Acta Obstet Gynecol Scand, 1998; 77: 603-608","DOI":"10.1034\/j.1600-0412.1998.770605.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Ertorer ME, Guvenc B, Haydardedeoglu B, Tekinturhan F. A case report of the cascade filtration system: a safe and effective method for low-density lipoprotein apheresis during pregnancy. Ther Apher Dial, 2008; 12: 396-400","DOI":"10.1111\/j.1744-9987.2008.00616.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Ogura M, Makino H, Kamiya C, Yoshimatsu J, Soran H, Eatough R, Perrone G, Harada-Shiba M, Stefanutti C. Lipoprotein apheresis is essential for managing pregnancies in patients with homozygous familial hypercholesterolemia: Seven case series and discussion. Atherosclerosis, 2016; 254: 179-183","DOI":"10.1016\/j.atherosclerosis.2016.10.018"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Harada-Shiba M, Arai H, Ohmura H, Okazaki H, Sugiyama D, Tada H, Dobashi K, Matsuki K, Minamino T, Yamashita S, Yokote K. Guidelines for the Diagnosis and Treatment of Adult Familial Hypercholesterolemia 2022. J Atheroscler Thromb, 2023; 30: 558-586","DOI":"10.5551\/jat.CR005"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Nakashima M, Yasui M, Ihara A. Fibrinogen salvage during DF Thermo using Evaflux-5A plasma fractionators. Ther Apher Dial, 2012; 16: 472-477","DOI":"10.1111\/j.1744-9987.2012.01140.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Hayashi H., Takemura M., Hashimoto H. The experience of double-filtration plasmapheresis thermo-mode (DF thermo) for hemodialysis patients with severe ASO. Nihon Toseki Igakkai Zasshi, 2007; 40: 89-94","DOI":"10.4009\/jsdt.40.89"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Koga N, Nagano T, Sato T, Kagasawa K. Anaphylactoid reactions and bradykinin generation in patients treated with LDL-apheresis and an ACE inhibitor. ASAIO J, 1993; 39: M288-M291","DOI":"10.1097\/00002480-199307000-00027"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/33\/1\/33_65360\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T04:18:11Z","timestamp":1767413891000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/33\/1\/33_65360\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.65360","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"type":"print","value":"1340-3478"},{"type":"electronic","value":"1880-3873"}],"subject":[],"published":{"date-parts":[[2026,1,1]]},"article-number":"65360"}}